Retatrutide

Retatrutide is an investigational peptide that acts as a triple agonist of the GLP-1, GIP, and glucagon receptors. This multi-receptor design has positioned Retatrutide as a unique molecule within metabolic research, as it engages three distinct hormonal pathways involved in energy regulation. GLP-1 and GIP receptor activation are associated with incretin signaling related to insulin secretion, satiety, and nutrient metabolism. The addition of glucagon receptor activity introduces a separate metabolic pathway involved in energy expenditure and lipid metabolism. Researchers are studying how the combined activation of these systems may influence overall metabolic efficiency and energy utilization. Scientific investigations into Retatrutide…